The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ligand Pharmaceuticals Incorporated competitive analysis

Loading summary...

Latest oppositions filed by Ligand Pharmaceuticals Incorporated

Explore patent oppositions filed by Ligand Pharmaceuticals Incorporated against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3022231
CyclodextrinCURADEV PHARMA PVTJan 18, 2019
EP2786657
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSOct 31, 2018

Latest PTAB cases involving Ligand Pharmaceuticals Incorporated

Discover the latest PTAB cases involving Ligand Pharmaceuticals Incorporated, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ligand Pharmaceuticals Incorporated with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LIGAND PHARMACEUTICALS INCORPORATED2 - - -
CURADEV PHARMA PVT - 1 - -
REGENERON PHARMACEUTICALS3894931